115 related articles for article (PubMed ID: 32750943)
1. Quantitative Whole Slide Assessment of Tumor-Infiltrating CD8-Positive Lymphocytes in ER-Positive Breast Cancer in Relation to Clinical Outcome.
Krijgsman D; van Leeuwen MB; van der Ven J; Almeida V; Vlutters R; Halter D; Kuppen PJK; van de Velde CJH; Wimberger-Friedl R
IEEE J Biomed Health Inform; 2021 Feb; 25(2):381-392. PubMed ID: 32750943
[TBL] [Abstract][Full Text] [Related]
2. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
[TBL] [Abstract][Full Text] [Related]
3. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.
Hartman DJ; Ahmad F; Ferris RL; Rimm DL; Pantanowitz L
Oral Oncol; 2018 Nov; 86():278-287. PubMed ID: 30409313
[TBL] [Abstract][Full Text] [Related]
4. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.
Lea D; Watson M; Skaland I; Hagland HR; Lillesand M; Gudlaugsson E; Søreide K
Cancer Immunol Immunother; 2021 Jul; 70(7):2049-2057. PubMed ID: 33439293
[TBL] [Abstract][Full Text] [Related]
5. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
Ziai J; Gilbert HN; Foreman O; Eastham-Anderson J; Chu F; Huseni M; Kim JM
PLoS One; 2018; 13(1):e0190158. PubMed ID: 29320521
[TBL] [Abstract][Full Text] [Related]
7. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis.
Cai M; Zhao K; Wu L; Huang Y; Zhao M; Hu Q; Chen Q; Yao S; Li Z; Fan X; Liu Z
Chin Med J (Engl); 2024 Feb; 137(4):421-430. PubMed ID: 38238158
[TBL] [Abstract][Full Text] [Related]
9. Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.
Blok EJ; van den Bulk J; Dekker-Ensink NG; Derr R; Kanters C; Bastiaannet E; Kroep JR; van de Velde CJ; Kuppen PJ
Oncotarget; 2017 Feb; 8(9):15610-15620. PubMed ID: 28121628
[TBL] [Abstract][Full Text] [Related]
10. Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer.
Abe N; Matsumoto H; Takamatsu R; Tamaki K; Takigami N; Uehara K; Kamada Y; Tamaki N; Motonari T; Unesoko M; Nakada N; Zaha H; Yoshimi N
Virchows Arch; 2020 May; 476(5):701-709. PubMed ID: 31873876
[TBL] [Abstract][Full Text] [Related]
11. Analytical validation of quantitative immunohistochemical assays of tumor infiltrating lymphocyte biomarkers.
Singh U; Cui Y; Dimaano N; Mehta S; Pruitt SK; Yearley J; Laterza OF; Juco JW; Dogdas B
Biotech Histochem; 2018; 93(6):411-423. PubMed ID: 29863904
[TBL] [Abstract][Full Text] [Related]
12. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1
Liang H; Li H; Xie Z; Jin T; Chen Y; Lv Z; Tan X; Li J; Han G; He W; Qiu N; Jiang M; Zhou J; Xia H; Zhan Y; Cui L; Guo W; Huang J; Zhang X; Wu YL
Thorac Cancer; 2020 Oct; 11(10):2941-2954. PubMed ID: 32894006
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer.
Jäntti T; Luhtala S; Mäenpää J; Staff S
Tumour Biol; 2020 Nov; 42(11):1010428320971404. PubMed ID: 33169632
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Infiltrating Lymphocytes as a Predictive Factor for Recurrence in Patients with Curatively Resected Colon Cancer: A Propensity Score Matching Analysis.
Chan LF; Sadahiro S; Suzuki T; Okada K; Miyakita H; Yamamoto S; Kajiwara H
Oncology; 2020; 98(10):680-688. PubMed ID: 32526753
[TBL] [Abstract][Full Text] [Related]
15. Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
Mukherjee G; Bag S; Chakraborty P; Dey D; Roy S; Jain P; Roy P; Soong R; Majumder PP; Dutt S
PLoS One; 2020; 15(11):e0242058. PubMed ID: 33211709
[TBL] [Abstract][Full Text] [Related]
16. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
[TBL] [Abstract][Full Text] [Related]
17. Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients.
Chan MS; Wang L; Felizola SJ; Ueno T; Toi M; Loo W; Chow LW; Suzuki T; Sasano H
Int J Biol Markers; 2012 Dec; 27(4):e295-304. PubMed ID: 23280127
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
19. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
